Biomatters LIMITED

Biomatters LIMITED is a bioinformatics software company that provides specialized software solutions to various U.S. federal agencies. The company's primary offering appears to be Geneious, a suite of molecular biology and genomic analysis tools, with Geneious Prime being their flagship bioinformatics software platform. Biomatters LIMITED, through its subsidiary Biomatters Incorporated, has secured multiple federal contracts to supply software and related services to government agencies involved in scientific research and analysis. The company's expertise lies in developing and delivering advanced bioinformatics tools that support genomic data management, analysis, and visualization.

Recent federal contract awards to Biomatters LIMITED demonstrate a consistent pattern of providing software subscriptions, licenses, and related services to a diverse range of civilian agencies. The National Institutes of Health's National Cancer Institute, the U.S. Department of Agriculture's Marketing and Regulatory Programs Business Services, the Smithsonian Institution's Office of the Chief Information Officer, and the Centers for Disease Control and Prevention have all awarded contracts to Biomatters. These awards typically involve annual software subscriptions, Geneious service contracts, and specialized software capabilities such as GenBank, SnapGene, and FASTQ data management, as well as external database search automation and custom algorithm development. Contract values have ranged from approximately $12,800 to $243,127, with performance periods generally spanning one to five years. Notably, none of the contracts reviewed had set-aside designations, indicating that Biomatters competes for these awards in the open market. The company's repeated success in securing contracts across multiple agencies underscores its strong position in providing critical bioinformatics tools to support federal scientific research efforts.